Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lea Wagmann

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
Therapeutic Drug Monitoring|October 6, 2023
Sample Matrices for Mass Spectrometry-Based Adherence Monitoring: A Systematic Critical ReviewCathy M Jacobs, Lea Wagmann, Markus R Meyer
Toxicology Letters|June 21, 2016
What is the contribution of human FMO3 in the N-oxygenation of selected therapeutic drugs and drugs of abuse?Lea Wagmann, Markus R Meyer, Hans H Maurer
Journal of Chromatography. A|September 28, 2017
An easy and fast adenosine 5'-diphosphate quantification procedure based on hydrophilic interaction liquid chromatography-high resolution tandem mass spectrometry for determination of the in vitro adenosine 5'-triphosphatase activity of the human breast cancer resistance protein ABCG2Lea Wagmann, Hans H Maurer, Markus R Meyer
Molecules (Basel, Switzerland)|August 29, 2024
Prevalence of Drugs of Abuse and Cognitive Enhancer Consumption Monitored in Grab Samples and Composite Wastewater via Orbitrap Mass Spectrometry AnalysisFabian Frankenfeld, Lea Wagmann, Cathy M Jacobs, et al.
Clinical Chemistry and Laboratory Medicine|October 31, 2019
Method development for quantitative determination of seven statins including four active metabolites by means of high-resolution tandem mass spectrometry applicable for adherence testing and therapeutic drug monitoringLea Wagmann, Selina Hemmer, Achim T Caspar, et al.
Journal of Chromatography. A|May 2, 2024
Impact of four different extraction methods and three different reconstitution solvents on the untargeted metabolomics analysis of human and rat urine samplesSelina Hemmer, Sascha K Manier, Lea Wagmann, et al.
Metabolomics : Official Journal of the Metabolomic Society|April 30, 2024
Comparison of reversed-phase, hydrophilic interaction, and porous graphitic carbon chromatography columns for an untargeted toxicometabolomics study in pooled human liver microsomes, rat urine, and rat plasmaSelina Hemmer, Sascha K Manier, Lea Wagmann, et al.
Archives of Toxicology|April 22, 2020
Toxicometabolomics of the new psychoactive substances α-PBP and α-PEP studied in HepaRG cell incubates by means of untargeted metabolomics revealed unexpected amino acid adductsSascha K Manier, Lea Wagmann, Veit Flockerzi, et al.
Journal of Analytical Toxicology|September 8, 2022
Clinical Toxicological Follow-Up Analysis of a Suicide Attempt Using ChloroquineCathy M Jacobs, Lea Wagmann, Fabian Frankenfeld, et al.
Drug Testing and Analysis|November 28, 2023
Quantitative analysis of drugs of abuse and cognitive enhancers in influent wastewater by means of two chromatographic methodsFabian Frankenfeld, Lea Wagmann, Cathy M Jacobs, et al.
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Therapeutic Drug Monitoring|October 6, 2023
Sample Matrices for Mass Spectrometry-Based Adherence Monitoring: A Systematic Critical ReviewCathy M Jacobs, Lea Wagmann, Markus R Meyer
Toxicology Letters|June 21, 2016
What is the contribution of human FMO3 in the N-oxygenation of selected therapeutic drugs and drugs of abuse?Lea Wagmann, Markus R Meyer, Hans H Maurer
Journal of Chromatography. A|September 28, 2017
An easy and fast adenosine 5'-diphosphate quantification procedure based on hydrophilic interaction liquid chromatography-high resolution tandem mass spectrometry for determination of the in vitro adenosine 5'-triphosphatase activity of the human breast cancer resistance protein ABCG2Lea Wagmann, Hans H Maurer, Markus R Meyer
Molecules (Basel, Switzerland)|August 29, 2024
Prevalence of Drugs of Abuse and Cognitive Enhancer Consumption Monitored in Grab Samples and Composite Wastewater via Orbitrap Mass Spectrometry AnalysisFabian Frankenfeld, Lea Wagmann, Cathy M Jacobs, et al.
Clinical Chemistry and Laboratory Medicine|October 31, 2019
Method development for quantitative determination of seven statins including four active metabolites by means of high-resolution tandem mass spectrometry applicable for adherence testing and therapeutic drug monitoringLea Wagmann, Selina Hemmer, Achim T Caspar, et al.
Journal of Chromatography. A|May 2, 2024
Impact of four different extraction methods and three different reconstitution solvents on the untargeted metabolomics analysis of human and rat urine samplesSelina Hemmer, Sascha K Manier, Lea Wagmann, et al.
Metabolomics : Official Journal of the Metabolomic Society|April 30, 2024
Comparison of reversed-phase, hydrophilic interaction, and porous graphitic carbon chromatography columns for an untargeted toxicometabolomics study in pooled human liver microsomes, rat urine, and rat plasmaSelina Hemmer, Sascha K Manier, Lea Wagmann, et al.
Archives of Toxicology|April 22, 2020
Toxicometabolomics of the new psychoactive substances α-PBP and α-PEP studied in HepaRG cell incubates by means of untargeted metabolomics revealed unexpected amino acid adductsSascha K Manier, Lea Wagmann, Veit Flockerzi, et al.
Journal of Analytical Toxicology|September 8, 2022
Clinical Toxicological Follow-Up Analysis of a Suicide Attempt Using ChloroquineCathy M Jacobs, Lea Wagmann, Fabian Frankenfeld, et al.
Drug Testing and Analysis|November 28, 2023
Quantitative analysis of drugs of abuse and cognitive enhancers in influent wastewater by means of two chromatographic methodsFabian Frankenfeld, Lea Wagmann, Cathy M Jacobs, et al.
Pageof 8